Company: CRNX
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0000950170-25-029050
Chunk: 92

Company: Crinetics Pharmaceuticals, Inc.
Filing Date: 2025-02-27
Form: 10-K
Item: Item 14
Chunk 92
---
    R. Scott Struthers, Ph.D.
     
     (principal executive officer)

    /s/ Marc J.S. Wilson
     
    Chief Financial Officer
     
    February 27, 2025

    Marc J.S. Wilson
     
     (principal financial and accounting officer)

    /s/ Wendell Wierenga, Ph.D.
     
    Chairman of the Board of Directors
     
    February 27, 2025

    Wendell Wierenga, Ph.D.

    /s/ Camille Bedrosian, M.D.
     
    Director
     
    February 27, 2025

    Camille Bedrosian, M.D.

    /s/ Caren Deardorf
     
    Director
     
    February 27, 2025

    Caren Deardorf

    /s/ Matthew K. Fust
     
    Director
     
    February 27, 2025

    Matthew K. Fust

    /s/ Weston Nichols, Ph.D.
     
    Director
     
    February 27, 2025

    Weston Nichols, Ph.D.

    /s/ Stephanie Okey
     
    Director
     
    February 27, 2025

    Stephanie Okey

    /s/ Rogério Vivaldi Coelho, M.D.
     
    Director
     
    February 27, 2025

    Rogério Vivaldi Coelho, M.D.

i